Keeping the right track in the treatment of patients with type 2 diabetes

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine. ,vol. 358, pp. 2560- 2572 ,(2008) , 10.1056/NEJMOA0802987

, Basal insulin and cardiovascular and other outcomes in dysglycemia The New England Journal of Medicine. ,vol. 367, pp. 319- 328 ,(2012) , 10.1056/NEJMOA1203858

S. Saad, J. Zhang, R. Yong, D. Yaghobian, M. G. Wong, D. J. Kelly, X. M. Chen, C. A. Pollock, Role of the EGF receptor in PPARγ-mediated sodium and water transport in human proximal tubule cells Diabetologia. ,vol. 56, pp. 1174- 1182 ,(2013) , 10.1007/S00125-013-2835-Y

Jacob A Udell, Matthew A Cavender, Deepak L Bhatt, Saurav Chatterjee, Michael E Farkouh, Benjamin M Scirica, Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials The Lancet Diabetes & Endocrinology. ,vol. 3, pp. 356- 366 ,(2015) , 10.1016/S2213-8587(15)00044-3

Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman, Matthew A Cavender, Jacob A Udell, Nihar R Desai, Ofri Mosenzon, Darren K McGuire, Kausik K Ray, Lawrence A Leiter, Itamar Raz, Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus The New England Journal of Medicine. ,vol. 369, pp. 1317- 1326 ,(2013) , 10.1056/NEJMOA1307684

U. Quast, D. Stephan, S. Bieger, U. Russ, The Impact of ATP-Sensitive K+ Channel Subtype Selectivity of Insulin Secretagogues for the Coronary Vasculature and the Myocardium Diabetes. ,vol. 53, ,(2004) , 10.2337/DIABETES.53.SUPPL_3.S156

Shirley Rubler, Joel Dlugash, Yusuf Ziya Yuceoglu, Tarik Kumral, Arthur Whitley Branwood, Arthur Grishman, New type of cardiomyopathy associated with diabetic glomerulosclerosis The American Journal of Cardiology. ,vol. 30, pp. 595- 602 ,(1972) , 10.1016/0002-9149(72)90595-4

E. Konduracka, A. Gackowski, P. Rostoff, D. Galicka-Latala, W. Frasik, W. Piwowarska, Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy European Heart Journal. ,vol. 28, pp. 2465- 2471 ,(2007) , 10.1093/EURHEARTJ/EHM361

Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Silvio E Inzucchi, None, Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. The New England Journal of Medicine. ,vol. 373, pp. 2117- 2128 ,(2015) , 10.1056/NEJMOA1504720

E. Ferrannini, B. Balkau, Insulin: in search of a syndrome. Diabetic Medicine. ,vol. 19, pp. 724- 729 ,(2002) , 10.1046/J.1464-5491.2002.00794.X